| Healthy controls (n = 30) | ES patients (n = 45) | P-value |
---|---|---|---|
Clinical characteristics | Â | ||
 Age, years | 38.4 ± 14.8 | 36.6 ± 11.1 | 0.588 |
 Female, n, % | 18 (60.0) | 32 (71.1) | 0.331 |
 BSA, m2 | 1.6 ± 0.1 | 1.6 ± 0.2 | 0.987 |
 BMI, kg/m2 | 22.1 ± 2.5 | 20.2 ± 3.5 | 0.009 |
 SBP, mmHg | 119 ± 8 | 113 ± 16 | 0.031 |
 DBP, mmHg | 73 ± 5 | 70 ± 11 | 0.145 |
 HR, bpm | 76 ± 7 | 89 ± 16 |  < 0.001 |
 Hct, % | 0.43 ± 0.03 | 0.53 ± 0.11 |  < 0.001 |
 Plt, 109/L | – | 150 ± 47 | – |
 NT-pro BNP, pg/mL | – | 460 (83—1515) | – |
 Tnt, ng/L | – | 10.9 ± 7.7 | – |
 6MWT, m | – | 424 ± 92 | – |
 WHO class I/II/III/IV, n | – | 2/27/16/0 | – |
 SpO2, % | – | 86 ± 5 | – |
Hemodynamic characteristics | |||
 mRAP, mmHg | – | 7 ± 4 | – |
 mPAP, mmHg | – | 68 ± 20 | – |
 PAWP, mmHg | – | 10 ± 4 | – |
 Qp:Qs | – | 1.0 ± 0.3 | – |
 PVRI, Wood units × m2 | – | 26.1 ± 14.3 | – |
 CI, L/min/m2 |  | 2.2 ± 0.7 | – |
 SvO2, % | – | 61.2 ± 9.5 | – |